ES2187215T3 - Derivados de aril-4-fluoro-4-(2-piridin-2-il-etilamino)-metil)-piperidin-1-il-metanona como agonistas del receptor 5-ht1. - Google Patents

Derivados de aril-4-fluoro-4-(2-piridin-2-il-etilamino)-metil)-piperidin-1-il-metanona como agonistas del receptor 5-ht1.

Info

Publication number
ES2187215T3
ES2187215T3 ES99970390T ES99970390T ES2187215T3 ES 2187215 T3 ES2187215 T3 ES 2187215T3 ES 99970390 T ES99970390 T ES 99970390T ES 99970390 T ES99970390 T ES 99970390T ES 2187215 T3 ES2187215 T3 ES 2187215T3
Authority
ES
Spain
Prior art keywords
piperidin
fluoro
derivatives
metanone
piridin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99970390T
Other languages
English (en)
Inventor
Bernard Vacher
Bernard Bonnaud
Wouter Koek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Application granted granted Critical
Publication of ES2187215T3 publication Critical patent/ES2187215T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Compuestos de fórmula general (1)**(Fórmula)** en la que X representa un átomo de flor, de cloro o de hidrógeno, así como las sales de adición de los compuestos de fórmula general (1) con los ácidos minerales o los ácidos orgánicos farmacéuticamente aceptables.
ES99970390T 1998-10-09 1999-10-07 Derivados de aril-4-fluoro-4-(2-piridin-2-il-etilamino)-metil)-piperidin-1-il-metanona como agonistas del receptor 5-ht1. Expired - Lifetime ES2187215T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9812660A FR2784378B1 (fr) 1998-10-09 1998-10-09 Nouveaux derives d'aryl-(4-fluoro-4-[(2-pyridin-2-yl- ethylamino)-methyl]-piperidin-1-yl)-methanone, leur procede de preparation et leur utilisation a titre de medicaments

Publications (1)

Publication Number Publication Date
ES2187215T3 true ES2187215T3 (es) 2003-05-16

Family

ID=9531367

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99970390T Expired - Lifetime ES2187215T3 (es) 1998-10-09 1999-10-07 Derivados de aril-4-fluoro-4-(2-piridin-2-il-etilamino)-metil)-piperidin-1-il-metanona como agonistas del receptor 5-ht1.

Country Status (14)

Country Link
US (1) US6448268B1 (es)
EP (1) EP1119564B1 (es)
JP (1) JP2003514764A (es)
CN (1) CN1160348C (es)
AT (1) ATE229951T1 (es)
AU (1) AU761122B2 (es)
BR (1) BR9914331A (es)
CA (1) CA2346506C (es)
DE (1) DE69904626T2 (es)
DK (1) DK1119564T3 (es)
ES (1) ES2187215T3 (es)
FR (1) FR2784378B1 (es)
WO (1) WO2000021953A1 (es)
ZA (1) ZA200102942B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2840900B1 (fr) * 2002-06-18 2005-02-25 Pf Medicament Nouveaux derives d'aryl[4-halogeno-4- [(heteroaryl-methylamino)-methyl]-piperidin-1-yl]-methanone, leur procede de preparation et leur utilisation a titre de medicaments
FR2852244B1 (fr) * 2003-03-13 2007-09-07 Pf Medicament Utilisation de derives de pyridin-2-yl-methylamine pour la preparation d'un medicament destine au traitement des symptomes de la douleur chronique d'origine neuropathique ou psychogene
EP3260452A1 (en) * 2016-06-24 2017-12-27 Neurolixis Compounds for treating disorders sensitive to serotoninergic regulation controlled by the 5-ht1a receptors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0661266A1 (en) * 1993-12-27 1995-07-05 Toa Eiyo Ltd. Substituted cyclic amine compounds as 5HT2 antagonists
FR2755967B1 (fr) * 1996-11-21 1999-01-29 Pf Medicament Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
FR2784378B1 (fr) 2000-12-29
DK1119564T3 (da) 2003-04-07
DE69904626T2 (de) 2003-10-23
CN1325396A (zh) 2001-12-05
AU761122B2 (en) 2003-05-29
ZA200102942B (en) 2002-05-02
DE69904626D1 (en) 2003-01-30
CA2346506C (fr) 2009-01-13
US6448268B1 (en) 2002-09-10
WO2000021953A1 (fr) 2000-04-20
AU5990599A (en) 2000-05-01
JP2003514764A (ja) 2003-04-22
EP1119564B1 (fr) 2002-12-18
FR2784378A1 (fr) 2000-04-14
EP1119564A1 (fr) 2001-08-01
CN1160348C (zh) 2004-08-04
ATE229951T1 (de) 2003-01-15
BR9914331A (pt) 2001-06-26
CA2346506A1 (fr) 2000-04-20

Similar Documents

Publication Publication Date Title
ATE433962T1 (de) Piperazinylpyrazinverbindungen als antagonisten des serotonin-5-ht2-rezeptors
IL155702A0 (en) Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5-ht2 receptor
BR0307960A (pt) N-aminoacetil-pirrolidina-2-carbonitrilas e seu uso como inibidores de ddp-iv
PA8467101A1 (es) Compuestos 4-(2-ceto-1-benzilimidazolinil)piperidina como agonistas del receptor orli
ATE435206T1 (de) Heteroarylsulfonylstilbene als 5-ht2a- antagonisten
TW200732303A (en) Novel fused pyrrole derivatives
MXPA02000973A (es) Benzofurilpiperazinas y benzofurilhomopiperazinas: agonistas de serotonina.
MX2009002229A (es) Benzotriazoles como moduladores de cinasas.
MXPA05007115A (es) Nuevos agonistas inversos del receptor cb 1.
DE602004018630D1 (en) Substituierte 3-cyanothiophen acetamide als glucagon receptor antagonisten
ES2187215T3 (es) Derivados de aril-4-fluoro-4-(2-piridin-2-il-etilamino)-metil)-piperidin-1-il-metanona como agonistas del receptor 5-ht1.
MXPA04004981A (es) Derivados de piperazina para uso como antagonistas del receptor ccr-3 en tratamiento de asma.
ATE253058T1 (de) Piperidin- und piperazin derivate als 5-ht1- rezeptor-agonisten
DE602004018811D1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
MXPA05008601A (es) Derivados de benzamida como agonistas de oxitocina y antagonistas de vasopresina.
MXPA03002937A (es) Benzimidazoles n-alcoxialquil-substituidos y su uso como agentes contra protozoos parasitantes.
MXPA04001977A (es) Antagonistas v de receptor ccr-3.
BR0111074A (pt) N-hidroxiformamidas biciclil ou heterobiciclilme-tanossulfonilamino-substituìdos
MXPA05012279A (es) Derivados de bencil sulfonamida.
HUP0301608A2 (hu) Klórozott pirimidinek szintézise
YU23301A (sh) Postupak za dobijanje supstituisanih piridina
YU39603A (sh) Jedinjenja piperazinilpirazina kao antagonisti serotonin 5-ht2 receptora
MXPA03002532A (es) Nuevos compuestos de indolina, un proceso para su preparacion y composiciones farmaceuticas que los contienen.
DE69909273D1 (de) Phosphat-vermittelte cyclisierung
DK1242390T3 (da) Fremgangsmåde til fremstilling af 1,3-disubstituerede 2-nitroguanidiner